Seeking Alpha

It's likely to be a rough day for Idenix Pharmaceuticals (IDIX) after yesterday's announcement...

It's likely to be a rough day for Idenix Pharmaceuticals (IDIX) after yesterday's announcement regarding IDX20963. The shares are off 33% premarket and the downgrades are coming in fast. JPMorgan, JMP, and Deutsche Bank have all cut the shares and Baird has started the stock at Underperform.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|